ANIP files Form 144 to sell 6,000 common shares

ANIP submitted a Form 144 notice reporting a proposed sale of 6,000 common shares through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

ANIP submitted a Form 144 notice reporting a proposed sale of 6,000 common shares through Morgan Stanley Smith Barney LLC. The filing lists restricted stock lots dated 04/27/2023 (1,698 shares), 05/23/2024 (3,865 shares) and 05/21/2025 (437 shares).

Insights

Securities Compliance Attorney

Form 144 notice reports a proposed resale of restricted common stock totaling 6,000 shares.

Form 144 is a regulatory notice enabling a holder to effect a public resale of restricted or control securities in reliance on Rule 144. The filing lists specific restricted stock lots with grant dates and share counts that support the proposed sale.

Practical implications depend on whether the broker clears trades and whether volume/holding-period conditions of Rule 144 are met; timing and proceeds treatment are not stated in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ANIP's Form 144 report?

The filing reports a proposed resale of 6,000 common shares. It lists restricted stock lots dated 04/27/2023 (1,698), 05/23/2024 (3,865) and 05/21/2025 (437).

Who is the broker handling the proposed sale for ANIP?

The broker shown is Morgan Stanley Smith Barney LLC. The filing lists that broker as the executing broker for the proposed sale but does not state timing or execution details.

Are the securities in ANIP's Form 144 restricted or unrestricted?

The filing identifies the listed securities as Restricted Stock. Each lot entry includes a grant date and share count, indicating these are restricted shares subject to resale conditions.

Does the Form 144 state how proceeds will be used?

The excerpt does not state any use-of-proceeds or who will receive sale proceeds. The filing focuses on the quantities, broker, and grant dates for the restricted shares.

When was ANIP's Form 144 filed or dated in the excerpt?

The excerpt includes a date field showing 03/03/2026 near the filer header. Individual restricted-stock grant dates are 04/27/2023, 05/23/2024, and 05/21/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001720568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI Pharmaceuticals, Inc.
SEC File Number	001-31812
Address of Issuer	210 Main Street West Baudette MINNESOTA 56623
Phone	(218) 634-3500
Name of Person for Whose Account the Securities are To Be Sold	PATRICK WALSH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	445390.20	22414104	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock	Issuer			437	05/21/2025	Not Applicable
Common	04/27/2023	Restricted Stock	Issuer			1698	04/27/2023	Not Applicable
Common	05/23/2024	Restricted Stock	Issuer			3865	05/23/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Dennis Walsh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)